share_log

復星醫藥:海外監管公告 - 關於股東部分股份解除質押的公告

FOSUN PHARMA: Overseas Regulatory Announcement - Announcement Regarding the Release of Pledged Shares by Shareholders

HKEX ·  Dec 3, 2024 02:10

Summary by Moomoo AI

截至2024年12月2日,復星高科技持有復星醫藥約35.99%的股份,其中部分A股已解除質押。本次解除質押的股份數量為20,000,000股,佔其所持股份的2.08%,佔公司總股份的0.75%。解除質押後,復星高科技質押的股份餘額為513,800,000股,約佔公司總股份的19.23%。復星高科技及其一致行動人合計持有復星醫藥約36.23%的股份,解除質押後,質押股份餘額為513,800,000股,佔其持有股份的53.09%。復星高科技確認未來可能有新的質押計劃,並將根據實際情況及法律要求履行告知義務。公司將按規定及時披露相關信息。此次公告由復星醫藥董事會於2024年12月3日發布,董事長吳以芳代表公司確認公告內容的真實性、準確性和完整性,並承擔法律責任。
截至2024年12月2日,復星高科技持有復星醫藥約35.99%的股份,其中部分A股已解除質押。本次解除質押的股份數量為20,000,000股,佔其所持股份的2.08%,佔公司總股份的0.75%。解除質押後,復星高科技質押的股份餘額為513,800,000股,約佔公司總股份的19.23%。復星高科技及其一致行動人合計持有復星醫藥約36.23%的股份,解除質押後,質押股份餘額為513,800,000股,佔其持有股份的53.09%。復星高科技確認未來可能有新的質押計劃,並將根據實際情況及法律要求履行告知義務。公司將按規定及時披露相關信息。此次公告由復星醫藥董事會於2024年12月3日發布,董事長吳以芳代表公司確認公告內容的真實性、準確性和完整性,並承擔法律責任。
As of December 2, 2024, Fustar Hi-Tech held approximately 35.99% of the shares of Fustar Pharmaceuticals, of which a portion of the A shares were unpledged. The number of shares outstanding at this time was 20,000,000 shares, representing 2.08% of the shares held and 0.75% of the total shares of the company. After the liquidation of the escrow, the balance of the shares held by Fustar Hi-Tech was 513,800,000 shares, representing approximately 19.23% of the total shares of the company.FUSTAR HI-TECH AND ITS CONSISTENT CARRIER JOINTLY HOLD APPROXIMATELY 36.23% OF THE SHARES IN FUSTAR PHARMACEUTICALS. AFTER THE DEMOBILIZATION OF THE PLEDGE, THE BALANCE OF THE PLEDGED SHARES IS 513,800,000 SHARES, REPRESENTING 53.09% OF ITS HOLDINGS. FUSTAR HI-TECH CONFIRMS THAT THERE MAY BE NEW COLLATERAL SCHEMES IN...Show More
As of December 2, 2024, Fustar Hi-Tech held approximately 35.99% of the shares of Fustar Pharmaceuticals, of which a portion of the A shares were unpledged. The number of shares outstanding at this time was 20,000,000 shares, representing 2.08% of the shares held and 0.75% of the total shares of the company. After the liquidation of the escrow, the balance of the shares held by Fustar Hi-Tech was 513,800,000 shares, representing approximately 19.23% of the total shares of the company.FUSTAR HI-TECH AND ITS CONSISTENT CARRIER JOINTLY HOLD APPROXIMATELY 36.23% OF THE SHARES IN FUSTAR PHARMACEUTICALS. AFTER THE DEMOBILIZATION OF THE PLEDGE, THE BALANCE OF THE PLEDGED SHARES IS 513,800,000 SHARES, REPRESENTING 53.09% OF ITS HOLDINGS. FUSTAR HI-TECH CONFIRMS THAT THERE MAY BE NEW COLLATERAL SCHEMES IN THE FUTURE AND WILL FULFIL ITS NOTIFICATION OBLIGATIONS BASED ON ACTUAL CIRCUMSTANCES AND LEGAL REQUIREMENTS. The Company will disclose relevant information in a timely manner as required.This announcement was issued by the Board of Directors of Fustar Pharmaceuticals on December 3, 2024. Chairman Wu Yifang confirmed on behalf of the Company the authenticity, accuracy and completeness of the contents of the announcement and assumed legal responsibility.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more